Create, analyze, optimize your ETF portfolio. Start now →
iShares Biotechnology ETF
IBB performance and flow charts
Performance
Flows
Historic performance and flows
Data as of October 26, 2026| 1M | 3M | YTD | 1Y | 3Y | 5Y | |
|---|---|---|---|---|---|---|
| Perf. | -0.97% | +10.81% | +23.74% | +33.06% | +82.71% | +32.03% |
| Flows | +$168M | +$398M | +$487M | +$1.71B | -$135M | -$1.04B |
Characteristics
The iShares Biotechnology ETF is built to track the NYSE Biotechnology GTR Index - USD. This ETF provides physical exposure - by owning its shares you earn the return of the securities composing the index (as the ETF holds them directly). This share class generates a stream of income by distributing dividends.
| Management strategy | Passive |
| Strategy | Long Only |
| Provider | iShares |
| N° of holdings | 241 |
| Replication method | Direct (Physical) |
| Asset class | Equity |
| Dividend policy | Distributing |
Trailing 12m distribution yield | Join for free |
| Inception date | February 5, 2001 |
| ESG | No |
More data and info about IBB on Trackinsight
Exposure
Data as of August 31, 2026Diversification
Total weight of top 15 holdings out of 241
Top 15 Holdings
Sectors
Countries
Latest news about IBB
Similar ETFs
Trading data
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Volatility | +26.18% | +22.65% | +21.41% | +22.59% |
Max drawdown | -7.78% | -9.61% | -24.82% | -35.62% |
Max drawdown duration | 68d | 151d | 377d | 1468d |
Time to recover | N/A | 88d | 177d | 1244d |
Replication quality
Data as of September 30, 2026Create an account to view replication metrics
1 year cumulative return difference | |
|---|---|
| Best | Join for free |
| Worst | Join for free |
| daily return difference | |
|---|---|
| Average | Join for free |
| Worst | Join for free |
What type of ETF is IBB?
IBB is a Passive ETF that provides exposure to Equity assets. It is managed by iShares.
What index does IBB track?
IBB tracks the NYSE Biotechnology GTR Index - USD, aiming to replicate its performance through full replication.
What does IBB invest in?
This ETF provides exposure to US Biotechnology Equities. It is part of the segment: US Health Care.
What is the expense ratio of IBB?
The total expense ratio (TER) of IBB is 0.44%, representing the annual fee charged by the fund manager.
When was IBB launched?
IBB was launched on February 5, 2001, marking its entry into the ETF market.
Who is the issuer of IBB?
IBB is issued by iShares.
What is the AUM of IBB?
As of October 26, 2026, IBB manages $10.75 B, reflecting the total assets held in the fund.
How has IBB performed recently?
As of October 26, 2026, IBB delivered a return of -0.97% over the past month (1M performance), 10.81% over the past three months (3M), and 23.74% year-to-date (YTD).
What are the recent fund flows for IBB?
As of October 26, 2026, IBB has seen net flows of +$168M in the past month (1M flow) and +$487M year-to-date (YTD).
Does IBB pay dividends?
As of October 26, 2026, IBB has a trailing 12-month distribution yield of 0.16%.
How many holdings are in IBB
As of August 31, 2026, IBB holds 241 securities in its portfolio. This level of diversification can influence the fund’s risk profile and exposure to individual assets.
How diversified is IBB?
As of August 31, 2026, IBB holds 241 securities, with 56.64% of its assets concentrated in its top 15 holdings.
What are the top holdings of IBB?
As of August 31, 2026, IBB holds a portfolio of 241 underlyings, with its largest positions including Amgen, Inc., Vertex Pharmaceuticals, Inc. and Gilead Sciences, Inc.. These top holdings play a significant role in shaping the fund’s performance and exposure.
What countries or regions does IBB invest in?
As of August 31, 2026, IBB has its largest geographic exposures in USA.
What sectors or themes does IBB focus on?
As of August 31, 2026, IBB is primarily exposed to Healthcare.
Advantages of ETFs over Mutual Funds1/6
Lower Costs
In this guide, we'll explore the advantages of ETFs over mutual funds, giving you valuable insights into why ETFs have gained significant popularity among investors like yourself.
Leveraged ETFs: Unlocking the Potential for Amplified Returns1/6
Understanding Leveraged ETFs
Explore leveraged ETFs: potential for amplified returns & risks. 5 ETFs to consider across equities, commodities & fixed income.
What is a Leveraged ETF?1/6
Introducing Leveraged and Inverse ETFs
In this guide, we'll dive into the world of leveraged ETFs, exploring their definition, mechanics, potential risks, and rewards.
Recent educational content
First Look ETF
First Look ETF: Income, International, and Cash Flow ETFs
In this season 6 episode of First Look ETF, Stephanie Stanton @etfguide examines the latest ETF marketplace trends with NYSE and guests.
ETF Trends
ETF Industry KPIs October 5, 2026
This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.
ETF Trends
ETF Industry KPIs September 28, 2026
This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.
ETF Trends
ETF Industry KPIs September 22, 2026
This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.
